Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment 2025-08-26 14:29
Basecare Medical (02170.HK) Gems Culture Medium Receives First Approval from NMPA, Advancing the Localization of Assisted Reproductive Fluids 2025-08-26 11:47
Fullerton Health Announces Strategic Investment by Mitsubishi Corporation 2025-08-26 10:00
MORROW founder invests US $156m and launches new flagship in Singapore as US $8 trillion longevity revolution ramps up 2025-08-26 08:00
Infinitus Named in Liaowang Institution's "Leading Transparent Factory Case Studies" 2025-08-26 02:55
Neopharma Technologies and Orient Gene Partner to Digitize Healgen® Drug Test Portfolio Globally with NEOVAULT® 2025-08-26 02:10
Henlius Keeps Steady Growth in H1 2025: Overseas Product Profits Soar 200%+, Innovation Fuels Global Reach 2025-08-25 21:18
Everest Medicines Announces Participation in September Investor Conferences 2025-08-25 20:57
Peijia Medical Announces 2025 Interim Results 2025-08-25 20:00
Acceleration in Clinical Development! Leads Biolabs' LBL-034 Dosed First Patient in Phase Ⅱ Trial 2025-08-25 18:27
Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer 2025-08-25 16:42
Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy 2025-08-25 15:43
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints 2025-08-25 13:46
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts 2025-08-25 12:01
Manulife Hong Kong and Macau Strengthens Leadership Team to Advance Health, Product, and Strategy 2025-08-25 12:00
Harbour BioMed Appoints Yajie Li as Chief Medical Officer 2025-08-25 09:00
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer 2025-08-25 08:00
MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MH WELLNESS FAIR 2025, CHAMPIONING HEALTHY YOUTHS 2025-08-23 17:46
WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES 2025-08-22 20:00
Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform 2025-08-22 18:14